Hong Kong:PD-L1 testing review

Hong Kong SAR China
Collaboration

General details

The rapid expansion observed in PD-L1/PD-1 precision medicine in the last few years has resulted in confusion regarding how optimal PD-L1 testing should be performed, with:
- 4 commercially available assays existing in the market alongside numerous standalone antibodies
- Recommendations regarding scoring algorithms and clinical cut-offs varying depending on the assay-indication combination

This collaboration will be used to generate information for a peer reviewed article that focuses on the identification of barriers for optimal and consistent use of PD-L1 testing across multiple indications, clones and platforms. Content will be presented in an aggregated and anonymized manner

As part of this collaboration, you will receive:
- One free of charge PD-L1 cell microarray block covering a dynamic range of PD-L1. The block will yield 300 – 350 cut slides for you to use as required.
- The opportunity to benchmark yourself with other PD-L1 users who have chosen to participate in this collaboration

Requirements

To be eligible to participate in this collaboration please ensure that:

1.Your lab profile information reflects:
a.Available in-house IHC auto-stainer details
b.External Quality Assurance (EQA) schemes or proficiency testing (PT) programs that are being subscribed to for PD-L1 testing

2.Your lab assay details reflect:
a.Current PD-L1 testing methods and turnaround times
b.Scoring algorithms and reporting formats
c.Q1, Q2 and Q3 2020 PD-L1 volumes for indications covered within your service
d.Q1, Q2 & Q3 2020 indication volumes

*Please note, where multiple assays are available in-house, these have to be logged as individual assays per antibody

Documentation

Booking policies

Cancellation policy: Flexible

> If the asker cancels more than 1 day(s) before the start of the booking, he is reimbursed 100 % of the amount paid
> If the asker cancels less than 1 day(s) before the start of the booking , he is reimbursed 50 % of the amount paid

Requirements

To be eligible to participate in this collaboration please ensure that:

1.Your lab profile information reflects:
a.Available in-house IHC auto-stainer details
b.External Quality Assurance (EQA) schemes or proficiency testing (PT) programs that are being subscribed to for PD-L1 testing

2.Your lab assay details reflect:
a.Current PD-L1 testing methods and turnaround times
b.Scoring algorithms and reporting formats
c.Q1, Q2 and Q3 2020 PD-L1 volumes for indications covered within your service
d.Q1, Q2 & Q3 2020 indication volumes

*Please note, where multiple assays are available in-house, these have to be logged as individual assays per antibody

Location

Calendar

Diaceutics

United Kingdom

Member since 13 Aug, 2020
Ask a question or directly offer to participate in a collaboration.